Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Pandolfi (Pavia, Italy), V. Frangipane (Pavia, Italy), A. Urzainqui (Madrid, Spain), A. Marengo (Paris, France), K. Bohne-Japiassu (Paris, France), V. Codullo (Pavia, Italy), L. Cavagna (Pavia, Italy), V. Vertui (Pavia, Italy), S. Bozzini (Pavia, Italy), M. Morosini (Pavia, Italy), S. Castañeda (Madrid, Spain), E. Fattal (Paris, France), F. Meloni (Pavia, Italy). Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis. 4242

Member's Comments

No comment yet.

Related content which might interest you: A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Exercise Pulmonary Vascular Resistances are Predictors of Survival in Systemic Sclerosis Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Safety and Efficacy of High-Intensity Aerobic Exercise and Strength Training in Interstitial Lung Disease (ILD) Patients Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Intratumoral Hyperthermic Chemotherapy Injection in Peripheral Non-Small Cell Lung Cancer; a Pilot Study. Source: Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons Year: 2020 A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Aerobic and Weightlifting Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Overweight Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Oral presentation: A New Target and Novel Agent to Prevent Acute Lung Injury Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Use of Airway Epithelial Cell Cultures in Inflammatory Lung Disease Research Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019